Home › Hemophilia B › Michigan › Ann Arbor
Hemophilia B clinical trials in Ann Arbor, MI
4 studies for Hemophilia B are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
RecruitingPhase 3
- University of Michigan Medical Center, Ann Arbor
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
RecruitingPhase 1/2
- University of Michigan, Ann Arbor
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
RecruitingPhase 3
- University of Michigan, Ann Arbor
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
RecruitingPhase 1Healthy volunteers welcome
- University of Michigan Hospitals - Michigan Medicine, Ann Arbor
Hemophilia B trials in other cities
- Philadelphia, PA5 studies
- Sacramento, CA4 studies
- Los Angeles, CA4 studies
- Houston, TX4 studies
- Atlanta, GA4 studies
- Seattle, WA3 studies
- San Francisco, CA3 studies
- Indianapolis, IN3 studies
- Greenville, NC3 studies
- Nashville, TN3 studies
- Gainesville, FL3 studies
Other studies in Ann Arbor
- Breast Cancer27 studies
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Cancer (all types)25 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Stroke12 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.